Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 126.0 | 53 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 130.0 | 59 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | SCGF-b | 141.0 | 70 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 184.5 | 88 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 148.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 158.0 | 77 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 89.5 | 76 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 122.0 | 77 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 115.0 | 82 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 145.0 | 72 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 148.0 | 84 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 181.0 | 59 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 99.0 | 87 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 196.0 | 63 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 163.0 | 60 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 142.0 | 61 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 164.0 | 57 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 165.0 | 53 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 188.0 | 71 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 145.0 | 71 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 139.0 | 75 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 101.0 | 77 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 213.0 | 85 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 133.0 | 74 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 142.0 | 67 |